Sang W. Son
Ansan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Factors Predicting Guselkumab Treatment Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post Hoc Analysis of Korean Real-World Data.
Journal: Journal of clinical medicine
Published: November 19, 2025
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 30, 2025
Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trial.
Journal: Stem cell research & therapy
Published: May 30, 2025
Consensus-Based Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): Basic Therapy, Topical Therapy, and Conventional Systemic Therapy.
Journal: Annals of dermatology
Published: January 08, 2025
Effectiveness and Safety of Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis in Real-World Practice in Korea: A Prospective, Multicenter, Observational, Postmarketing Surveillance Study.
Journal: The Journal of dermatology
Published: December 02, 2024
Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study.
Journal: The Journal of dermatology
Published: November 26, 2024
Bridging the Gap: Comparing Patient-Clinician Views on Treatment Goals and Communication in the Management of Atopic Dermatitis Within the Asia-Pacific Region.
Journal: Dermatology and therapy
Published: May 27, 2024
Management of Moderate-to-Severe Atopic Dermatitis in Adults: A Cross-Sectional Survey of Dermatologists Within the Asia-Pacific Region.
Journal: Dermatology and therapy
Published: May 27, 2024
Quality of Life and Burden of Moderate-to-Severe Atopic Dermatitis in Adult Patients Within the Asia-Pacific Region: A Cross-sectional Survey.
Journal: Dermatology and therapy
Published: May 27, 2024
2023 Consensus Korean Diagnostic Criteria for Atopic Dermatitis.
Journal: Annals of dermatology
Published: May 06, 2024
Phase 1/2 trials of human bone marrow-derived clonal mesenchymal stem cells for treatment of adults with moderate to severe atopic dermatitis.
Journal: The Journal of allergy and clinical immunology
Published: January 18, 2024
Last Updated: 09/26/2026